Related references
Note: Only part of the references are listed.The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers
Wei Han et al.
CANCER PREVENTION RESEARCH (2009)
Atypical Protein Kinase Cι Is Required for Bronchioalveolar Stem Cell Expansion and Lung Tumorigenesis
Roderick P. Regala et al.
CANCER RESEARCH (2009)
Protein kinase Cε: an oncogene and emerging tumor biomarker
Michael A. Gorin et al.
MOLECULAR CANCER (2009)
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Qi-Wen Fan et al.
SCIENCE SIGNALING (2009)
A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
Jennifer Beane et al.
CANCER PREVENTION RESEARCH (2008)
PIK3CA mutations and copy number gains in human lung cancers
Hiromasa Yamamoto et al.
CANCER RESEARCH (2008)
The nuclear affairs of PTEN
Sarah M. Planchon et al.
JOURNAL OF CELL SCIENCE (2008)
Enabling personalized cancer medicine through analysis of gene-expression patterns
Laura J. van 't Veer et al.
NATURE (2008)
Class IPI3K in oncogenic cellular transformation
L. Zhao et al.
ONCOGENE (2008)
Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival
Maria Teresa Landi et al.
PLOS ONE (2008)
KEGG for linking genomes to life and the environment
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2008)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
Berengere Marty et al.
BREAST CANCER RESEARCH (2008)
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/triple-negative'' breast cancer cell lines growing in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Targeting mTOR signaling in lung cancer
Marin Marinov et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Molecular concepts analysis links tumors, pathways, mechanisms, and drugs
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
Fei Huang et al.
CANCER RESEARCH (2007)
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer
Avrum Spira et al.
NATURE MEDICINE (2007)
Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression
Jennifer Beane et al.
GENOME BIOLOGY (2007)
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
S. Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A phase I study of myo-inositol for lung cancer chernoprevention
Stephen Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Oncogenic PI3K deregulates transcription and translation
AG Bader et al.
NATURE REVIEWS CANCER (2005)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Distinctions in the specificity of E2F function revealed by gene expression signatures
EP Black et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer
YM Miyazu et al.
CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers
P Michl et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Atypical protein kinase C in insulin action and insulin resistance
RV Farese et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
JA Engelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Loss of heterozygosity on 10q23.3 and mutation of tumor suppressor gene PTEN in gastric cancer and precancerous lesions
Yi-Ling Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Inositol pentakisphosphate promotes apoptosis through the PI3-K/Akt pathway
E Piccolo et al.
ONCOGENE (2004)
Promoter hypermethylation of resected bronchial margins: A field defect of changes?
MZ Guo et al.
CLINICAL CANCER RESEARCH (2004)
Effects of cigarette smoke on the human airway epithelial cell transcriptome
A Spira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Adjustment of systematic microarray data biases
M Benito et al.
BIOINFORMATICS (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Gene expression phenotypic models that predict the activity of oncogenic pathways
E Huang et al.
NATURE GENETICS (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Digital karyotyping
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation
T Kamalati et al.
ONCOGENE (2000)
Share Paper
